Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Amended: McGraw-Hill Companies Q1 Profit Up; Backs 2012 Adj. EPS View - Quick Facts

Amended: corrects company name in the headline.

McGraw-Hill Companies (MHP: Quote) reported a rise in first-quarter net income attributable to the company to $123 million or $0.43 per share from $120 million or $0.39 per share in the prior-year quarter.

Revenue for the latest quarter totaled $1.33 billion, up 6% from $1.26 billion a year earlier.

On average, 7 analysts polled by Thomson Reuters expected earnings per share of $0.48 on $1.32 billion revenue for the quarter. Analysts' estimates typically exclude one-time items.

Looking forward, the company still sees full-year 2012 adjusted earnings in the range of $3.25 - $3.35 per share, while 8 analysts project 2012 earnings of $3.33 per share.

Click here to receive FREE breaking news email alerts for McGraw-Hill Companies Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Nike Inc., the world's largest athletic shoes and apparel maker, said Thursday after the markets closed that its second quarter profit rose 23% from last year, helped by higher revenue and improved gross margin. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue. Citing extreme fluctuation of the ruble, Apple Inc. (AAPL) has reportedly discontinued its online sales of products in Russia. Despite efforts of the Russian central bank, the ruble has been spiraling downward, with oil prices plunging to historic levels. The ruble shed around 19 percent on Wednesday.... General Motors said it has halted the delivery of cars to dealerships in Russia as it strives to overcome the business risks stemming from the collapse of the ruble.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.